Residents of Afghanistan, Angola, Burundi, Benin, Burkina Faso, Bangladesh, Bhutan, Central African Republic, Côte d’Ivoire, Cameroon, Congo, Dem. Rep., Congo, Rep., Comoros, Cabo Verde, Djibouti, Algeria, Egypt, Arab Rep., Eritrea, Ethiopia, Micronesia, Fed. Sts., Ghana, Guinea, Gambia, The, Guinea-Bissau, India, Iran, Islamic Rep., Jordan, Kenya, Kyrgyz Republic, Cambodia, Kiribati, Lao PDR, Lebanon, Liberia, Sri Lanka, Lesotho, Morocco, Madagascar, Mali, Myanmar, Mongolia, Mozambique, Mauritania. Malawi, Niger, Nigeria, Nepal, Pakistan, Philippines, Papua New Guinea, Korea, Dem. People’s Rep., Rwanda, Sudan, Senegal, Solomon Islands, Sierra Leone, Somalia, South Sudan, Eswatini, Syrian Arab Republic, Chad, Togo, Tajikistan, Timor-Leste, Tunisia, Tanzania, Uganda, Ukraine, Uzbekistan, Vietnam, Vanuatu, Samoa, Yemen, Rep., Zambia and Zimbabwe
Call for abstract
Last deadline for abstract submission
May 31, 2024
Communication of Selected Abstracts
June 24, 2024
Deadline for Author Registration
July 5, 2024
General regulations:
- The final deadline for submitting your abstract is May 31, 2024, 23:59 Colombia Time (CO/GMT-5).
- Authors with an accepted abstract may benefit from the early bird registration even if the deadline has expired.
- Abstracts will be accepted in English.
- One or more of the authors of the abstract must be registered for the ISH 2024 Congress for the abstract to be presented either as a poster or an oral presentation.
- Registration must be completed before June 24, 2024 (pending abstract acceptance). Otherwise, the abstract will not be included in the Abstract Book or be eligible to be presented at the congress.
- The abstract can list a maximum of 15 authors, including the author presenting at the Conference, and 10 affiliations. Those submitting abstracts must indicate which author will present the work.
- An individual can present a maximum of 3 abstracts at the ISH 2024 congress.
- Submission of abstracts of previously published work is not allowed. If the data presented are additional to a published study, the data may be submitted.
- The submission of an abstract implies authorization by the co-authors for the work to be published in the ISH 2024 Congress Abstract Book. The presenting author must ensure that all co-authors are aware of the content of the abstract before submission.
- Authors must disclose any conflicts of interest via the abstract submission form. A section has been provided for this purpose in the submission platform.
- Authors can request their work to be presented orally or either as a poster; however, the committee will decide the presentation format & will inform the submitting author about this.
- Abstract acceptance notifications will be sent by June 10, 2024.
- The Scientific Committee reserves the right to reject an abstract that does not comply with the general regulations.
- It is important for authors to pay special attention to the grammar & spelling in their abstract submissions, as well as to the scientific content.
Abstract Structure:
- The abstract must have a maximum of 350 words including the title.
- Title: Maximum of 30 words, must be written in CONTINUOUS CAPITAL LETTERS and, if abbreviations are included, they must be standard type abbreviations.
- Authors: Each author will be required to provide their name and all the information required of each author in the abstract submission form (Position, institution, city, country, etc.).
- Content: The abstract should include the following sections:
- Background and Objective
- Methods
- Results
- Conclusions
- Only one figure or table is allowed per abstract.
- The author must carefully read the abstract before sending it.
- A confirmation of receipt of the abstract will be automatically sent to the registered email address upon submission.
- Hypertension in children & adolescents
- Hypertension in old & very old
- Application of AI in hypertension
- Precision medicine
- Global health & regional differences
- Environmental factors & social determinants
- Models of care & novel strategies for BP control
- Digital therapeutics
- Endocrine & secondary hypertension
- Metabolism, diabetes & obesity
- Blood pressure measurement & diagnosis
- Applied research & translational medicine
- Imaging & Biomarkers
- Mechanisms of hypertension mediated target organ damage
- New treatment strategies
- Cardiovascular risk in individuals & population
- Genetics, epigenetics & phenotypes
- Lifestyle & sports
- Clinical trials
- Guidelines implementation
- Educational Programmes
- Experimental pharmacology
- Growth & circulatory factors
- Pathophysiology & haemodynamics
- Intakes & nutrition
- Neural & reflex mechanisms
- Vasoactive substances
- Ion transport & signal transduction
- Pregnancy
- Hypertension in special populations
- Prevention & control
- Arterial function
- Circadian rhythms & BP variability
- Kidney disease
- Cerebrovascular disease
- Heart disease
Please carefully review the Awards and Grants eligibility and criteria, before submitting your preferred abstracts.
Requests sent after the abstract submission deadline will not be considered.
Submit your abstract by May 31, 2024, May 31, 2024, 23:59 Colombia Time (CO/GMT-5).
Abstract Submission Portal